PhotoThera, based in Carlsbad, CA, is developing a proprietary, light-based therapy, called transcranial laser therapy (TLT) for the treatment of neurological diseases and disorders. The company’s first product, NeuroThera, is an investigational device that seeks to improve neurological outcomes in stroke patients via noninvasive delivery of near-infrared laser energy into the brain. PhotoThera’s clinical trials have demonstrated both the safety of the TLT treatment and statistically significant effectiveness for certain cohorts of stroke patients using a post-hoc data analysis.
In April 2009, Warburg Pincus led a Series D financing of PhotoThera, the proceeds of which are being used to fund the follow-on clinical trial for NeuroThera.
Back
to Previous Page